Outlook Therapeutics said in a filing that the U.S. Food and Drug Administration has approved LYTENAVA (bevacizumab-vikg) for the treatment of wet age-related macular degeneration, making it the first FDA-approved ophthalmic formulation of bevacizumab in the United States.
At the beginning of 2009, a project was officially launched unlike anything else before it. This project is what we know as Bitcoin, and it sparked the development of a billion-dollar industry that has beaten the odds stacked against it. There are bound to be some interesting facts and pointers relevant to how a project…
A global report released by Ripple Labs titled “New Value: Crypto Trends In Business & Beyond” found that over 76% of financial institutions throughout the world intend to utilize cryptocurrencies within the next 3 years. The report focuses on “the role of key blockchain use cases like payments and DeFi, and the token types —…
Coverage · Geo-anchored ingest
19,624 stocks + ETFs + commodities + macro — social chatter, prices, fundamentals and rates, fused into one moving picture of the world's money.
Markets covered — select a market to open it
All our sources, feeding one distributed picture of the world's money — geo-anchored at the desks where it moves.
